Article
Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy.
The FEBS journal - 1 Jan 2010
Okamoto Isamu
Abstract excerpt
The discovery that signaling by the epidermal growth factor receptor (EGFR) plays a key role in tumorigenesis prompted efforts to target this receptor in anticancer therapy. Two different types of EGFR-targeted therapeutic agents were subsequently developed: mAbs, such as cetuximab and panitumumab, which target the extracellular domain of the receptor, thereby inhibiting ligand-dependent EGFR signal transduction;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
